Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program

Hum Vaccin Immunother. 2021 Nov 2;17(11):4611-4616. doi: 10.1080/21645515.2021.1967042. Epub 2021 Sep 20.

Authors

Paul Gaston Van Buynder¹, Angela Newbound², C Raina MacIntyre³, Alexander Thomas Kennedy⁴, Christopher Clarke⁴, Jonathan Anderson⁴

Affiliations

¹ School of Medicine, Griffith University, Southport, Australia.
² Independent Consultant, Semaphore, Australia.
³ Biosecurity Research Program, The Kirby Institute, University of New South Wales, Sydney, Australia.
⁴ Medical Affairs, Seqirus Pty Ltd, Melbourne, Australia.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Australia
COVID-19 Vaccines
COVID-19*
Humans
Influenza Vaccines*
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines
Influenza Vaccines

Grants and funding

This work was supported by the Seqirus Pty Ltd, Melbourne, Australia.